Pay to Marwadi

Company Profile

ARIHANT SUPERSTRUCTURES LTD.

NSE : ARIHANTSUPBSE : 506194ISIN CODE : INE643K01018Industry : Construction - Real EstateHouse : Private
BSE368.201.45 (+0.4 % )
PREV CLOSE (Rs.) 366.75
OPEN PRICE (Rs.) 364.95
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 11359
TODAY'S LOW / HIGH (Rs.)364.95 392.80
52 WK LOW / HIGH (Rs.)157.75 416.65
NSE368.05 1.45 (+0.4 % )
PREV CLOSE(Rs.) 366.60
OPEN PRICE (Rs.) 371.70
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 368.05 (1840 )
VOLUME 156330
TODAY'S LOW / HIGH(Rs.) 364.30 394.90
52 WK LOW / HIGH (Rs.)158.55 416

Board Meetings

Source Date Board Meeting Date Details
20-Mar-2024 23-Mar-2024 Inter alia, to consider and approve: - To consider and approve fund raising by way issue of securities including securities and warrants convertible into non convertible debt instruments Subject to approval of Board of Directors and approvals from the other regulatory authorities as may be required
16-Feb-2024 24-Feb-2024 Inter alia, to consider the following proposal: - 1) To take note of the performance evaluation of the Independent Directors for the financial year 2023-24 2) To consider and discuss the appointment of Ms. Tasneem Marfatia as company secretary and compliance officer of the company. 3) To take note of the terms of appointment of the Directors and Key Managerial Personnel and evaluation of increase / decrease in remuneration as per the performance evaluation submitted and taken on table by the board. 4) To consider any other matter with the permission of the Chair.
02-Feb-2024 12-Feb-2024 Quarterly Results
31-Oct-2023 07-Nov-2023 Quarterly Results & Inter alia, to consider:- b) To consider and approve the appointment of Chairman of Audit and Nomination & Remuneration Committee c) To consider and approve fund raising by way of issue of share warrants or any other securities through private placement/preferential issue or through any other permissible mode and/ or combination thereof as may be considered appropriate subject to approval from the shareholders and approvals from the other regulatory authorities as may be required.
04-Aug-2023 11-Aug-2023 Quarterly Results (Revised)
31-Jul-2023 10-Aug-2023 A.G.M. & Quarterly Results
22-May-2023 22-May-2023 Quarterly Results(Cancelled)
15-May-2023 22-May-2023 Quarterly Results & Final Dividend
27-Jan-2023 04-Feb-2023 Quarterly Results
04-Nov-2022 12-Nov-2022 Quarterly Results